Axillary dissection in the context of the biology of lymph node metastases

American Journal of Surgery

Volumn 180, Issue 4, 2000, Pages 278-283

  Gervasoni Jr , James E ^a,b,c   Taneja, Charu ^a,b   Chung, Maureen A ^b,d   Cady, Blake ^b,d  

^a ROGER WILLIAMS MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d WOMEN AND INFANTS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONFERENCE PAPER; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MASTECTOMY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

AXILLA; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; ORGAN SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 0033661731     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(00)00455-4     Document Type: Conference Paper

References (45)

1. Mastectomy performed by Lorenz Heister in the eighteenth century
2. Surgery of the breast
3. On the influence of inadequate operations on the theory of cancer
4. On free removal of mammary cancer with extirpation of the axillary glands as a necessary accompaniment
5. An improved method of the radical operation for carcinoma of the breast
6. The results of radical operations for the cure of carcinoma of the breast
7. Super radical operation for breast cancer in the patient with lymph node involvement
8. Radical mastectomy with parasternal and supraclavicular dissection for mammary carcinoma
9. Specificity of adhesion between murine tumor cells and capillary endothelium: An in vivo correlate of preferential metastasis in vivo
10. Metastatic patterns in soft tissue sarcomas
11. Surgical margin in hepatic resection for colorectal metastasis: A critical and improvable determinant of outcome
12. 3 to adhere to lymph node vitronectin
13. Vitronectin (serum spreading factor): Its localizations in normal and fibrotic tissue
14. Vitronectin, a glioma-derived extracellular matrix protein, protects tumor cells from apoptotic death
15. Rapid induction of cytokine and E-selectin expression in the liver in response to metastatic tumor cells
16. Liver endothelial E-selectin mediates carcinoma cell adhesion and promotes liver metastasis
17. Paracrine growth stimulation by hepatocytes-derived insulin-like growth factor-1: A regulatory mechanism for carcinoma cells metastatic to the liver
18. Evidence for the clonal origin of spontaneous metastases
19. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer
20. The pathobiology of metastasis within the lymphatic system
21. The National Cancer Data Base 10-year survey of breast cancer treatment at hospitals in the United States
22. Case against axillary lymphadenectomy for most patients with infiltrating breast cancer
23. Axillary dissection: Current practice and technique
24. Survival advantage of adjuvant chemotherapy in high risk node-negative breast cancer: Ten-year analysis
25. Ten-year results of a randomized trial comparing radical mastectomy and total mastectomy with or without radiation
26. Treatment outcome after tangential radiation therapy without axillary dissection in patients with early stage breast cancer and clinically negative axillary nodes
27. Axillary dissection can be avoided in selected breast cancer patients: Analysis of 401 cases
28. Predicting axillary node positivity in patients with invasive carcinoma of the breast by using a combination of T category and palpability
29. The biological and clinical significance of lymphatic metastases in breast cancer
30. Radical excision of the chest wall for mammary cancer
31. The dissection of internal mammary nodes does not improve the survival of breast cancer patients: 30-year results of a randomized trial
32. Simple mastectomy with postoperative irradiation versus extended radical mastectomy in breast cancer: A twenty-five year follow-up of a randomized trial
33. Should irradiation replace dissection for patients with clinically negative axillary lymph nodes?
34. Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer
35. Clinical behavior of untreated axillary nodes after local treatment for primary breast cancer
36. Cancer Research Campaign (King's/Cambridge) trial for early breast cancer
37. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma
38. Classification of isolated tumor cells and micrometastasis
39. Minimal solid tumor involvement of regional and distant sites
40. Sentinel lymph node biopsy and axillary dissection in breast cancer: Results in a large series
41. Lessons learned from 500 cases of lymphatic mapping for breast cancer
42. Histopathological validation of the sentinel node hypothesis for breast carcinoma
43. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?
44. Sentinel lymph node biopsy with metastasis: Can axillary dissection be avoided in some patients with breast cancer?
45. Mapping a pathway for axillary staging. A personal perspective on the current status of sentinel lymph node dissection for breast cancer